Spinraza® ▼ (nusinersen) Interim Data from Phase 2 Trial, NURTURE, Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
Why patients should be able to request an Upright Open MRI scan
Industry News from Medserena
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
News from GW Pharma
Phase 3 TOLEDO study results published
News from Britannia Pharmaceuticals
Rett UK
News from Rett UK
PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
News from Roche
UK’s Oldest Surgical College Gears Up for First-Ever Cycling Symposium Across Britain
Cyclists bid to spread the word on the latest news and advances in the field of surgery
Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign
‘Rules4Schools’ campaign news from Young Epilepsy and Veriton Pharma
Advantages and disadvantages of taking Z drugs to treat sleep disturbance in people with dementia
News from The Alzheimer’s Association International Conference (AAIC)
